Skip to main content

Advertisement

Log in

Friedreich ataxia is not only a GAA repeats expansion disorder: implications for molecular testing and counselling

  • Human Genetics • Original Paper
  • Published:
Journal of Applied Genetics Aims and scope Submit manuscript

Abstract

Friedreich ataxia (FRDA) is the most common hereditary ataxia. It is an autosomal recessive disorder caused by mutations of the FXN gene, mainly the biallelic expansion of the (GAA)n repeats in its first intron. Heterozygous expansion/point mutations or deletions are rare; no patients with two point mutations or a point mutation/deletion have been described, suggesting that loss of the FXN gene product, frataxin, is lethal. This is why routine FRDA molecular diagnostics is focused on (GAA)n expansion analysis. Additional tests are considered only in cases of heterozygous expansion carriers and an atypical clinical picture. Analyses of the parent’s carrier status, together with diagnostic tests, are performed in rare cases, and, because of that, we may underestimate the frequency of deletions. Even though FXN deletions are characterised as ‘exquisitely rare,’ we were able to identify one case (2.4 %) of a (GAA)n expansion/exonic deletion in a group of 41 probands. This was a patient with very early onset of disease with rapid progression of gait instability and hypertrophic cardiomyopathy. We compared the patient’s clinical data to expansion/deletion carriers available in the literature and suggest that, in clinical practice, the FXN deletion test should be taken into account in patients with early-onset, rapid progressive ataxia and severe scoliosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Anheim M, Mariani LL, Calvas P, Cheuret E, Zagnoli F, Odent S, Seguela C, Marelli C, Fritsch M, Delaunoy JP, Brice A, Dürr A, Koenig M (2012) Exonic deletions of FXN and early-onset Friedreich ataxia. Arch Neurol 69:912–916

    Article  PubMed  Google Scholar 

  • Bidichandani SI, Delatycki MB (1998) Friedreich ataxia. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K (eds) GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2015 [updated 2014 Jul 24]

  • Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Cañizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michele G, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel JL, Cocozza S, Koenig M, Pandolfo M (1996) Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423–1427

    Article  CAS  PubMed  Google Scholar 

  • Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, Trottier Y, Kish SJ, Faucheux B, Trouillas P, Authier FJ, Dürr A, Mandel JL, Vescovi A, Pandolfo M, Koenig M (1997) Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 6:1771–1780

    Article  CAS  PubMed  Google Scholar 

  • Cossée M, Schmitt M, Campuzano V, Reutenauer L, Moutou C, Mandel JL, Koenig M (1997) Evolution of the Friedreich’s ataxia trinucleotide repeat expansion: founder effect and premutations. Proc Natl Acad Sci U S A 94:7452–7457

    Article  PubMed  PubMed Central  Google Scholar 

  • Delatycki MB, Williamson R, Forrest SM (2000) Friedreich ataxia: an overview. J Med Genet 37:1–8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Deutsch EC, Santani AB, Perlman SL, Farmer JM, Stolle CA, Marusich MF, Lynch DR (2010) A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Mol Genet Metab 101:238–245

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Harding AE (1981) Friedreich’s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104:589–620

    Article  CAS  PubMed  Google Scholar 

  • Hoffman-Zacharska D, Mazurczak T (2008) Zastosowanie metody TP-PCR (Triplet Repeat Primed PCR) w diagnostyce molekularnej ataksji Friedreicha. Diag Lab 44:439–447

    CAS  Google Scholar 

  • Mazurczak T, Hoffman-Zacharska D (2009) Ataksja Friedreicha—algorytm diagnostyki klinicznej i molekularnej. Pediatria Polska 84:13–19

    Article  Google Scholar 

  • Montermini L, Andermann E, Labuda M, Richter A, Pandolfo M, Cavalcanti F, Pianese L, Iodice L, Farina G, Monticelli A, Turano M, Filla A, De Michele G, Cocozza S (1997) The Friedreich ataxia GAA triplet repeat: permutation and normal alleles. Hum Mol Genet 6(8):1261–1266

    Article  CAS  PubMed  Google Scholar 

  • Pandolfo M (2008) Friedreich ataxia. Arch Neurol 65:1296–1303

    Article  PubMed  Google Scholar 

  • Pandolfo M, Montermini L (1998) Prenatal diagnosis of Friedreich ataxia. Prenat Diagn 18:831–833

    Article  CAS  PubMed  Google Scholar 

  • Potdar PD, Raghu A (2013) Review on molecular diagnostic techniques in Friedreich’s ataxia. Annu Rev Res Biol 3(4):659–677

    CAS  Google Scholar 

  • Ryan F (2001) Best practice guidelines for molecular analysis of Friedreich ataxia. Best practice guidelines for molecular analysis of Friedreich ataxia (EMQN). Available online at: http://www.emqn.org/emqn/digitalAssets/0/234_FRDA.pdf

  • Schmitt M, Warner J, Barron L, Mandel J, Koenig M (2000) Detection of large (GAA)n repeat expansions by fluorescent PCR. Poster presented at the European Human Genetics Conference 2000, 32nd annual meeting of the European Society of Human Genetics (ESHG), Amsterdam, The Netherlands, May 2000

  • Sharma R, Bhatti S, Gomez M, Clark RM, Murray C, Ashizawa T, Bidichandani SI (2002) The GAA triplet-repeat sequence in Friedreich ataxia shows a high level of somatic instability in vivo, with a significant predilection for large contractions. Hum Mol Genet 11:2175–2187

    Article  CAS  PubMed  Google Scholar 

  • Tsou AY, Paulsen EK, Lagedrost SJ, Perlman SL, Mathews KD, Wilmot GR, Ravina B, Koeppen AH, Lynch DR (2011) Mortality in Friedreich ataxia. J Neurol Sci 307:46–49

    Article  PubMed  Google Scholar 

  • van den Ouweland AM, van Minkelen R, Bolman GM, Wouters CH, Becht-Noordermeer C, Deelen WH, Deelen-Manders JM, Ippel EP, Saris J, Halley DJ (2012) Complete FXN deletion in a patient with Friedreich’s ataxia. Genet Test Mol Biomarkers 16:1015–1018

    Article  PubMed  Google Scholar 

  • Warner JP, Barron LH, Goudie D, Kelly K, Dow D, Fitzpatrick DR, Brock DJ (1996) A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet 33:1022–1026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zühlke CH, Dalski A, Habeck M, Straube K, Hedrich K, Hoeltzenbein M, Konstanzer A, Hellenbroich Y, Schwinger E (2004) Extension of the mutation spectrum in Friedreich’s ataxia: detection of an exon deletion and novel missense mutations. Eur J Hum Genet 12:979–982

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was partially supported by grant 2P05E11529.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dorota Hoffman-Zacharska.

Additional information

Communicated by: Michal Witt

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoffman-Zacharska, D., Mazurczak, T., Zajkowski, T. et al. Friedreich ataxia is not only a GAA repeats expansion disorder: implications for molecular testing and counselling. J Appl Genetics 57, 349–355 (2016). https://doi.org/10.1007/s13353-015-0331-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13353-015-0331-4

Keywords

Navigation